Avanos Medical Inc AVNS.N, AVNS.K is expected to show a fall in quarterly revenue when it reports results on February 24 for the period ending December 31 2025
The Alpharetta Georgia-based company is expected to report a 2.7% decrease in revenue to $174.7 million from $179.6 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Avanos Medical Inc is for earnings of 25 cents per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated February 20 at 13:36 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)